Journal articles on the topic 'Assisted Reproductive Technology'

To see the other types of publications on this topic, follow the link: Assisted Reproductive Technology.

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Assisted Reproductive Technology.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Deep, JP. "Assisted Reproductive Technology." Journal of Chitwan Medical College 4, no. 1 (July 30, 2014): 1–10. http://dx.doi.org/10.3126/jcmc.v4i1.10840.

Full text
Abstract:
All the treatment or procedure that includes the handling of both human sperm and oocytes or embryos in vitro for the purpose of establishing a pregnancy in order to bypass some pathological obstacles in human reproduction is known as Assisted Reproductive Technology (ART). Now we must be approaching 1.5 million Assisted Reproductive Technology birth since the birth of the world’s first in vitro fertilization baby, Louise Brown, in the United Kingdom. The infertility is caused by various reason and factors from either or both partners. Infertility affects worldwide by 8-15 percent of couples in general and defined as a disease of the reproductive system by the failure to achieve a clinical pregnancy after one year or more of regular unprotected sexual intercourse. DOI: http://dx.doi.org/10.3126/jcmc.v4i1.10840 Journal of Chitwan Medical College 2014; 4(1): 1-10
APA, Harvard, Vancouver, ISO, and other styles
2

Silva, Shana Ginar da, Andréa Dâmaso Bertoldi, Mariângela Freitas da Silveira, Marlos Rodrigues Domingues, Kelly R. Evenson, and Iná Silva dos Santos. "Assisted reproductive technology." Revista de Saúde Pública 53 (January 30, 2019): 13. http://dx.doi.org/10.11606/s1518-8787.2019053000737.

Full text
Abstract:
OBJECTIVE: To assess the prevalence of successful assisted reproductive technology and to identify the associated factors. METHODS: This population-based birth cohort study was carried out with 4,333 pregnant women expected to deliver in 2015 in the urban area of Pelotas, Southern Brazil. Use of an assisted reproductive technology procedure, type of assisted reproductive technology [in vitro fertilization or intracytoplasmic sperm injection or artificial insemination], number of embryos transferred, success of embryo transfer, number of attempts, and reported reasons for seeking assisted reproductive technology were the main outcomes measured. Use of an assisted reproductive technology procedure was analyzed according to sociodemographic, nutritional, reproductive history, and behavioral characteristics. Unadjusted and adjusted analyses were performed by logistic regression. RESULTS: Among the 4,275 newborns enrolled in the Pelotas 2015 Birth Cohort Study, 18 births (0.4%) were conceived by assisted reproductive technology. Most cases of assisted reproductive technology were by in vitro fertilization (70.6%). All cycles were performed in private clinics under direct out-of-pocket payment. Even after controlling for confounders, maternal age > 35 years, nulliparity and high family monthly income were strongly associated with assisted reproductive technology. CONCLUSIONS: The use of assisted reproductive technology services was reported by only a few women in the Pelotas 2015 Birth Cohort Study. Our study highlights sociodemographic factors associated to assisted reproductive technology procedures. To better understand the patterns and barriers in overall use of assisted reproductive technology services over time, national-level trend studies in assisted reproductive technology treatments and outcomes, as well as studies exploring the characteristics of women who have sought this kind of treatment are needed in low-middle income countries.
APA, Harvard, Vancouver, ISO, and other styles
3

Yablonsky, Terri. "Assisted Reproductive Technology." Laboratory Medicine 27, no. 8 (August 1, 1996): 524–31. http://dx.doi.org/10.1093/labmed/27.8.524.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Tanbo, Tom, and Thomas Åbyholm. "Assisted reproductive technology." Current Opinion in Obstetrics and Gynecology 3, no. 5 (October 1991): 649–55. http://dx.doi.org/10.1097/00001703-199110000-00004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Watts, Robin. "Assisted reproductive technology." Collegian 4, no. 1 (January 1997): 12. http://dx.doi.org/10.1016/s1322-7696(08)60200-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Abe, Takashi, Ryoko Tomiyama, Tomoko Ichikawa, Katsuya Mine, Shigeo Akira, and Toshiyuki Takeshita. "5. Assisted Reproductive Technology A Trend of Assisted Reproductive Technology (I)." Nihon Ika Daigaku Igakkai Zasshi 5, no. 4 (2009): 184–86. http://dx.doi.org/10.1272/manms.5.184.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hogue, Carol J. Rowland. "Successful Assisted Reproductive Technology." Obstetrics & Gynecology 100, no. 5, Part 1 (November 2002): 1017–19. http://dx.doi.org/10.1097/00006250-200211000-00032.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Simón, Carlos. "Personalized assisted reproductive technology." Fertility and Sterility 100, no. 4 (October 2013): 922–23. http://dx.doi.org/10.1016/j.fertnstert.2013.08.011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Sacks, Preston C. "Assisted human reproductive technology." Reproductive Toxicology 6, no. 1 (January 1992): 109. http://dx.doi.org/10.1016/0890-6238(92)90028-r.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Sotoya Tsuyoshi. "Assisted Reproductive Technology and Bioethics." Journal of Next-Generation Humanities and Social Sciences ll, no. 14 (March 2018): 261–79. http://dx.doi.org/10.22538/jnghss.2018..14.261.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Pearn, John H. "Gatekeeping and assisted reproductive technology." Medical Journal of Australia 167, no. 6 (September 1997): 318–20. http://dx.doi.org/10.5694/j.1326-5377.1997.tb125078.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Balmaceda, Jose P., and Italo Ciuffardi. "HYSTEROSCOPY AND ASSISTED REPRODUCTIVE TECHNOLOGY." Obstetrics and Gynecology Clinics of North America 22, no. 3 (September 1995): 507–18. http://dx.doi.org/10.1016/s0889-8545(21)00200-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Machino, Saku. "Special Feature: Assisted Reproductive Technology." TRENDS IN THE SCIENCES 13, no. 8 (2008): 7. http://dx.doi.org/10.5363/tits.13.8_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

DeAngelis, Anthony, Anne Martini, and Carter Owen. "Assisted Reproductive Technology and Epigenetics." Seminars in Reproductive Medicine 36, no. 03/04 (May 2018): 221–32. http://dx.doi.org/10.1055/s-0038-1675780.

Full text
Abstract:
AbstractAssisted reproductive technology (ART) is responsible for 1.7% of births in the United States annually. Despite a large number of studies promoting the efficacy and safety of these practices, there have been reports of imprinting disorders occurring at higher frequencies in children born through ART. Driven by findings in animal studies, it has been postulated that various ART procedures employed at critical points in embryonic development may predispose the genomic imprinting process to errors. Alterations in DNA methylation patterns at imprinting control centers have been reported by some studies to occur more frequently in children with imprinting disorders conceived by ART compared with spontaneous conception, though these findings are not consistently demonstrated and controversy has surrounded the strength of these associations. The rarity of imprinting disorders with a reliance of studies on disease registry cohorts, wide variations in ART protocols, and a lack of proper control groups limit the ability to substantiate associations between imprinting disorders and ART. Large, prospective cohort studies with a focus on molecular etiologies of these conditions are needed to discern whether a true association exists. Based on current evidence, the absolute risk of imprinting disorders after ART is low and screening for imprinting disorders in children conceived by ART is not warranted.
APA, Harvard, Vancouver, ISO, and other styles
15

Schenker, Joseph G. "Assisted reproductive technology in Israel." Journal of Obstetrics and Gynaecology Research 33 (September 5, 2007): S51—S55. http://dx.doi.org/10.1111/j.1447-0756.2007.00612.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Van Voorhis, Bradley J. "Outcomes From Assisted Reproductive Technology." Obstetrics & Gynecology 107, no. 1 (January 2006): 183–200. http://dx.doi.org/10.1097/01.aog.0000194207.06554.5b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Fountain, Lily, and Cara J. Krulewitch. "TRENDS IN ASSISTED REPRODUCTIVE TECHNOLOGY." Journal of Midwifery & Women's Health 47, no. 5 (September 10, 2002): 384–85. http://dx.doi.org/10.1111/j.1542-2011.2002.tb04344.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Van Steirteghem, André. "Outcome of Assisted Reproductive Technology." New England Journal of Medicine 338, no. 3 (January 15, 1998): 194–95. http://dx.doi.org/10.1056/nejm199801153380312.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Greenfeld, Dorothy. "Infertility and Assisted Reproductive Technology." Social Work in Health Care 24, no. 3 (April 10, 1997): 39–46. http://dx.doi.org/10.1300/j010v24n03_04.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

KATAGIRI, YUKIKO, YUKIHIRO SHIBUI, KOICHI NAGAO, KAZUKIYO MIURA, and MINETO MORITA. "Epigenetics in assisted reproductive technology." Reproductive Medicine and Biology 6, no. 2 (May 14, 2007): 69–75. http://dx.doi.org/10.1111/j.1447-0578.2007.00168.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Malter, Henry E. "Micromanipulation in assisted reproductive technology." Reproductive BioMedicine Online 32, no. 4 (April 2016): 339–47. http://dx.doi.org/10.1016/j.rbmo.2016.01.012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Menezo, Yves, Stephane Viville, and Anna Veiga. "Epigenetics and assisted reproductive technology." Fertility and Sterility 85, no. 1 (January 2006): 269. http://dx.doi.org/10.1016/j.fertnstert.2005.10.005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Hilbert, SueLin M., and Stephanie Gunderson. "Complications of Assisted Reproductive Technology." Emergency Medicine Clinics of North America 37, no. 2 (May 2019): 239–49. http://dx.doi.org/10.1016/j.emc.2019.01.005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Corral, Hernán. "Filiation and Assisted Reproductive Technology." Revue générale de droit 31, no. 4 (December 18, 2014): 701–29. http://dx.doi.org/10.7202/1027998ar.

Full text
Abstract:
This article deals with the various filiation issues arising from the application of assisted reproduction techniques. The author asserts that assisted reproduction techniques produce a dissociation between the blood and genetic elements of procreation and people's will to become parents, which causes hard judicial dilemma in paternity suits. Legislative and judicial criteria developed both under European and American legal systems to solve this case are systematized in the article, wherein the author directs criticism to those criteria that tend to undermine the natural physiology of human reproduction in spite of the "intent of reproduction" concept. This latest concept is criticized as being a form of contractualization of filiation links. The author suggests that a deeper understanding of the human dignity, and of the international standard of the best interest of the child should be useful to protect children from being a part of the new market-of-human-beings that could arise from the massive application of assisted reproduction techniques.
APA, Harvard, Vancouver, ISO, and other styles
25

Porter, Misty. "Ultrasound in Assisted Reproductive Technology." Seminars in Reproductive Medicine 26, no. 3 (May 2008): 266–76. http://dx.doi.org/10.1055/s-2008-1076145.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Flyckt, Rebecca, Enrique Soto, and Tommaso Falcone. "Endometriomas and Assisted Reproductive Technology." Seminars in Reproductive Medicine 31, no. 02 (February 27, 2013): 164–72. http://dx.doi.org/10.1055/s-0032-1333482.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Maher, Eamonn R. "Imprinting and assisted reproductive technology." Human Molecular Genetics 14, suppl_1 (April 15, 2005): R133—R138. http://dx.doi.org/10.1093/hmg/ddi107.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Iliadou, A. N., P. C. J. Janson, and S. Cnattingius. "Epigenetics and assisted reproductive technology." Journal of Internal Medicine 270, no. 5 (September 14, 2011): 414–20. http://dx.doi.org/10.1111/j.1365-2796.2011.02445.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Kushnir, Vitaly A., David H. Barad, and Norbert Gleicher. "Defining assisted reproductive technology success." Fertility and Sterility 100, no. 4 (October 2013): e30. http://dx.doi.org/10.1016/j.fertnstert.2013.08.036.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Kissin, D. M., D. J. Jamieson, and W. D. Barfield. "Assisted Reproductive Technology Program Reporting." JAMA: The Journal of the American Medical Association 306, no. 23 (December 20, 2011): 2564. http://dx.doi.org/10.1001/jama.2011.1843.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Nayak, S. R., M. Milad, and R. Kazer. "Aneuploidy and assisted reproductive technology." Fertility and Sterility 90 (September 2008): S390. http://dx.doi.org/10.1016/j.fertnstert.2008.07.1527.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Zegers-Hochschild, Fernando, Ragaa Mansour, Osamu Ishihara, G. David Adamson, Jacques de Mouzon, Karl G. Nygren, and Elizabeth A. Sullivan. "International Committee for Monitoring Assisted Reproductive Technology: world report on assisted reproductive technology, 2005." Fertility and Sterility 101, no. 2 (February 2014): 366–78. http://dx.doi.org/10.1016/j.fertnstert.2013.10.005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Adamson, G. David, Jacques de Mouzon, Georgina M. Chambers, Fernando Zegers-Hochschild, Ragaa Mansour, Osamu Ishihara, Manish Banker, and Silke Dyer. "International Committee for Monitoring Assisted Reproductive Technology: world report on assisted reproductive technology, 2011." Fertility and Sterility 110, no. 6 (November 2018): 1067–80. http://dx.doi.org/10.1016/j.fertnstert.2018.06.039.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Nygren, Karl G., Elizabeth Sullivan, Fernando Zegers-Hochschild, Ragaa Mansour, Osamu Ishihara, G. David Adamson, and Jacques de Mouzon. "International Committee for Monitoring Assisted Reproductive Technology (ICMART) world report: assisted reproductive technology 2003." Fertility and Sterility 95, no. 7 (June 2011): 2209–22. http://dx.doi.org/10.1016/j.fertnstert.2011.03.058.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Peters, Kathleen, Debra Jackson, and Trudy Rudge. "Failures of reproduction: problematising ?success? in assisted reproductive technology." Nursing Inquiry 14, no. 2 (June 2007): 125–31. http://dx.doi.org/10.1111/j.1440-1800.2007.00363.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

DE MELO-MARTÍN, INMACULADA. "Assisted Reproductive Technology in Spain: Considering Women's Interests." Cambridge Quarterly of Healthcare Ethics 18, no. 3 (July 2009): 228–35. http://dx.doi.org/10.1017/s0963180109090379.

Full text
Abstract:
It might come as a surprise to many that Spain, a country with a strong Catholic tradition that officially banned contraceptive technologies until 1978, has some of the most liberal regulations in assisted reproduction in the world. Law No. 35/1988 was one of the first and most detailed acts of legislation undertaken on the subject of assisted-conception procedures. Indeed, not only did the law permit research on nonviable embryos, it made assisted reproductive technologies available to any woman, whether married or not, through the national healthcare system.
APA, Harvard, Vancouver, ISO, and other styles
37

Sun, Christie L., Sally L. Catt, Kiri Beilby, and Mulyoto Pangestu. "Cyclic nucleotide in oocyte In vitro maturation in Assisted Reproductive Technology." Journal of Biomedicine and Translational Research 6, no. 3 (December 23, 2020): 110–20. http://dx.doi.org/10.14710/jbtr.v6i3.9691.

Full text
Abstract:
In vitro maturation (IVM) is a promising assisted reproductive technology (ART) for human infertility treatment. However, when cumulus oocyte complexes (COCs) are removed from their follicular environment when manipulated in vitro, it can lead to a decrease of intra-oocyte cyclic adenosine 3’, 5’-monophosphare (cAMP) causing spontaneous nuclear maturation and an asynchrony with the oocytes’ cytoplasmic maturation, resulting in poor embryo developmental outcomes. Nuclear and cytoplasmic synchrony is important during oocyte maturation within antral follicles.It is maintained partially by the actions of c-type natriuretic peptide (CNP) binding with natriuretic peptide receptor 2 (NPR2), supporting high cAMP levels thus holding the oocyte in meiotic arrest. Addition of CNP to pre-IVM media has the capacity of maintaining cAMP levels and thus improve synchrony. Moreover, in women with advanced maternal age, successful IVM of aging oocytes faces significant challenges due to the morphological and cellular changes. Inhibiting initiation of nuclear maturation by cAMP modulator, CNP during pre-IVM period and thus improve oocyte developmental competence regardless of oocyte age.
APA, Harvard, Vancouver, ISO, and other styles
38

Fong, Alex, Robert Johnston, Steve Rad, Aaron Turner, Deyu Pan, and Dotun A. Ogunyemi. "Demographic and Medical Disparities in Assisted Reproductive Technology Compared With Non–Assisted Reproductive Technology Pregnancies." Obstetrics & Gynecology 123 (May 2014): 50S. http://dx.doi.org/10.1097/01.aog.0000447338.03689.10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Pierce, Nicole, and Edgar Mocanu. "Female age and assisted reproductive technology." Global Reproductive Health 3, no. 2 (June 2018): e9-e9. http://dx.doi.org/10.1097/grh.0000000000000009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Raimundo, JM, and P. Cabrita. "Artificial intelligence at assisted reproductive technology." Procedia Computer Science 181 (2021): 442–47. http://dx.doi.org/10.1016/j.procs.2021.01.189.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Chamsi-Pasha, Hassan, and Mohammed Ali Albar. "Assisted reproductive technology: Islamic Sunni perspective." Human Fertility 18, no. 2 (February 7, 2015): 107–12. http://dx.doi.org/10.3109/14647273.2014.997810.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Kirby, Russell S. "Assisted Reproductive Technology and Developmental Outcomes." Pediatrics 142, no. 6 (November 15, 2018): e20183072. http://dx.doi.org/10.1542/peds.2018-3072.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Syrkasheva, Anastasia G., Yana A. Petrosyan, and Natalia V. Dolgushina. "Gestagens in assisted reproductive technology programs." Gynecology 21, no. 2 (April 15, 2019): 76–79. http://dx.doi.org/10.26442/20795696.2019.2.190238.

Full text
Abstract:
Background. Luteal phase (LP) drug support is an important step in assisted reproductive technology (ART) programs efficacy. Aim. To present up-to-date data on an efficacy of LP hormonal support during ART cycles as well as to conduct a comparative analysis of various gestagen drug effectiveness. Materials and methods. To write this review domestic and foreign publications were searched in Russian and international search systems (PubMed, eLibrary, etc.) for the last 8 years. The review includs articles from peer-reviewed literature. Results. LP drug support becomes an essential step in infertility treatment in various ART programs. Although human chorionic gonadotropin drug injections in the posttransfer period leads to an activation of endogenous steroid hormones synthesis, exogenous hormones use is currently preferred because of not having a risk of ovarian hyperstimulation syndrome. Conclusions. The variety of progesterone drugs is accompanied by a lack of algorithms for their use in various clinical situations. Further studies are required to evaluate progesterone drugs efficacy for various subgroups of patients.
APA, Harvard, Vancouver, ISO, and other styles
44

Goldman, Kara N., Caroline McCaffrey, Joan Riley, Emily Jungheim, and Jamie A. Grifo. "Disaster preparedness in assisted reproductive technology." Fertility and Sterility 118, no. 2 (August 2022): 230–38. http://dx.doi.org/10.1016/j.fertnstert.2022.06.006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Kamath, MohanS, SeshKamal Sunkara, and Parimala Chinta. "Perinatal outcomes following assisted reproductive technology." Journal of Human Reproductive Sciences 12, no. 3 (2019): 177. http://dx.doi.org/10.4103/jhrs.jhrs_83_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Foti, Florentina-Larisa, and Adina Karner-Huțuleac. "Ethical Considerations in Assisted Reproductive Technology." Journal of Intercultural Management and Ethics 5, no. 1 (March 31, 2022): 43–48. http://dx.doi.org/10.35478/jime.2022.1.06.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Bahn, Geon Ho. "Psychoanalytic Aspects of Assisted Reproductive Technology." Psychoanalysis 28, no. 2 (April 30, 2017): 48–50. http://dx.doi.org/10.18529/psychoanal.2017.28.2.48.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Odendaal, Joshua, and Siobhan Quenby. "Immunological Testing in Assisted Reproductive Technology." Seminars in Reproductive Medicine 39, no. 01/02 (March 2021): 013–23. http://dx.doi.org/10.1055/s-0041-1730908.

Full text
Abstract:
AbstractFetal implantation requires carefully orchestrated involvement of the maternal immune system. Aberrant function within implantation has been suggested as a cause of implantation failure. The emergence of immunological theories of miscarriage has led to immunological testing as an adjuvant treatment in assisted reproductive technology; however, it remains controversial, with mixed evidence both for immunological cause and the benefits of immunological testing. Literature on common methods of immunological testing within assisted reproductive technology is reviewed including those of peripheral and uterine natural killer cells, chronic endometritis, and T-helper cells cytokine ratio. There is little consensus in the evidence on immunological testing in the context of recurrent implantation failure. The field is limited by a lack of uniformity in approach to testing and heterogeneity of the pathophysiological cause. Nevertheless, the maternal immune system is heavily involved in implantation and the new era of personalized medicine ensures that a more defined approach to immunological testing will be achieved.
APA, Harvard, Vancouver, ISO, and other styles
49

Stern, Judy E., and Hafsatou Diop. "Are assisted reproductive technology twins different?" Fertility and Sterility 116, no. 2 (August 2021): 355–56. http://dx.doi.org/10.1016/j.fertnstert.2021.05.102.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Messerli, Franz H., Théo A. Meister, Rodrigo Soria, Emrush Rexhaj, and Urs Scherrer. "Late repercussions of assisted reproductive technology." European Heart Journal 40, no. 44 (November 15, 2019): 3655. http://dx.doi.org/10.1093/eurheartj/ehz806.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography